ZXX2-77 is a selective cyclooxygenase-1 (COX-1) inhibitor used as an analgesic agent that does not cause gastric damage; however, it exhibits weak in vivo analgesic efficacy due to poor oral absorption. Despite its potent in vitro COX-1 inhibitory activity, its low systemic exposure limits its therapeutic effectiveness. It serves as a lead compound for developing COX-1-selective inhibitors with improved pharmacokinetic properties and minimal gastrointestinal side effects.